MDACC Study No:2009-0122 ( NCT No: NCT00924820)
Title:A Pilot Study of Systemically Administered Bevacizumab in Patients with Neoplastic Meningitis (NM)
Principal Investigator:Ivo Tremont
Treatment Agent:Bevacizumab
Study Status:Terminated
Study Description:The goal of this clinical research study is to learn if and how Avastin
(bevacizumab) may affect cancer that has spread to the meninges of the brain or
the spinal cord. The safety of this drug will also be studied.
Hide details for General InformationGeneral Information

Disease Group:Advanced Cancers; Brain; CNS
Phase of Study:N/A
Treatment Agents:Bevacizumab
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:N/A
Supported By:Genetech
Return Visit:Every two weeks
Home Care:N/A

Hide details for Study Contact InformationStudy Contact Information

Physician Name:Ivo Tremont
Dept:Neuro Oncology
For Clinical Trial Enrollment:713-792-2883
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults